Alveolar Bone Loss
Alveolar Bone Loss - Related Videos
11:05
Generation and Identification of GM-CSF Derived Alveolar-like Macrophages and Dendritic Cells From Mouse Bone Marrow
0 Views •
Cited by 18 •
2016
Bone marrow cells cultured with granulocyte macrophage colony stimulating factor (GM-CSF) generate a heterogeneous culture containing macrophages and dendritic cells (DCs). This method highlights using MHCII and hyaluronan (HA) binding to differentiate macrophages from the DCs in the GM-CSF culture. Macrophages in this culture have many similarities to alveolar macrophages.
10:39
Longitudinal Evaluation of Mouse Hind Limb Bone Loss After Spinal Cord Injury using Novel, in vivo, Methodology
0 Views •
Cited by 9 •
2011
A longitudinal examination of bone loss in the femurs and tibiae of adult mice was performed following spinal cord injury using sequential low-dose X-ray scans. Tibia bone loss was detected throughout the study, while bone loss in the femur was not detected until 40 days post injury.
07:45
Modeling Dysplastic and Functional Lung Alveolar Repair after Influenza Infection
0 Views •
2025
This protocol provides instructions for intranasal administration of IAV and downstream analysis of mouse lung damage and associated transcriptional changes to lung cell types.
09:04
Assessing Anti-fungal Activity of Isolated Alveolar Macrophages by Confocal Microscopy
0 Views •
Cited by 3 •
2014
A method to evaluate the ability of isolated mouse alveolar macrophages to control the growth of phagocytosed Aspergillus spores by confocal microscopy.
06:16
Microhardness Measurements on Tooth and Alveolar Bone in Rodent Oral Disease Models
0 Views •
Cited by 8 •
2024
Microhardness is a mechanical property and an informative parameter for evaluating hard tissue pathophysiology. Here, we demonstrate a standardized protocol (sample preparation, polishing, flat surface, and indentation sites) for microhardness analysis in tooth and alveolar bone in rodent oral disease models, namely, dental fluorosis, and ligature-induced periodontal bone resorption.
FAQs
RANKL links persistent immune activation to skeletal damage by promoting the differentiation of osteoclasts, the cells responsible for bone resorption. When bacterial biofilms sustain inflammation, immune-cell mediators can maintain this signaling environment. The resulting imbalance shifts local tissue activity toward mineralized-tissue breakdown, making RANKL an important mechanism connecting host defense with periodontal destruction.
Biofilms provide a continuing microbial stimulus that can maintain inflammatory signaling in periodontal tissues. Instead of resolving after a brief immune response, persistent exposure keeps immune cells active and supports mediator release, including signals associated with osteoclast differentiation. This interaction between microbial communities and host responses helps explain why tissue destruction can progress during chronic periodontal disease.
Immune cells do not merely respond to periodontal bacteria; their mediators can influence the cells that remove bone. In particular, RANKL promotes osteoclast differentiation, increasing the cellular capacity for resorption. This relationship shows how protective host-defense mechanisms can become damaging when inflammation persists, linking immune regulation directly to loss of bone supporting the teeth.
Evaluation combines radiographic and clinical assessment to identify changes in the bone supporting the teeth and to judge the extent of oral tissue destruction. Repeated measurements can help indicate whether disease is progressing or responding to treatment. These findings contribute to assessments of disease severity and prognosis rather than serving as an isolated laboratory measurement.
Changes in supporting bone provide an observable indicator of periodontal tissue destruction. Clinicians can use radiographic and clinical findings to assess disease severity, estimate prognosis, and evaluate response to treatment. Tracking these changes is especially relevant when inflammation and microbial biofilms remain central concerns, because structural outcomes connect biological activity with clinically meaningful disease progression.
The process serves as a model for examining how bacterial communities, host-defense responses, and inflammatory signaling interact to damage mineralized tissues. Researchers can relate immune-cell mediator activity, such as RANKL-associated signaling, to structural bone changes assessed clinically or radiographically. This context helps connect infection-driven inflammation with a measurable tissue outcome in oral disease.